ArticleFrontiers in microbiology2018
Characterization of a Multiresistance Plasmid Carrying the
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 58 citations in OpenAlex.
- Molecular Epidemiology, Phenotypic and Genomic Characterization of Multidrug-Resistant Enterococcus Faecium Isolated from Bovine Mastitis in Ningxia, China (2019-2024).Microorganisms · 2026Article
- Global dissemination of optrA-mediated linezolid resistance in enterococci.The Journal of antimicrobial chemotherapy · 2026Article
- Phenotypic and Molecular Characterization of Clinical Isolates of Vancomycin-ResistantPathogens (Basel, Switzerland) · 2026Article
- Spread of oxazolidinone-resistant enterococci in an Italian pig slaughterhouse.Frontiers in microbiology · 2026Article
- Genomic Characterization of Multiple Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Resistance to last-resort antibiotics in enterococci.FEMS microbiology reviews · 2025Review
- Non-Clinical microbiology reviews · 2024Review
- Recent development and fighting strategies for lincosamide antibiotic resistance.Clinical microbiology reviews · 2024Review
- High prevalence and plasmidome diversity ofFrontiers in microbiology · 2024Article
- Effect of TraN key residues involved in DNA binding on pIP501 transfer rates inFrontiers in molecular biosciences · 2024Article
- Various Mobile Genetic Elements Involved in the Dissemination of the Phenicol-Oxazolidinone Resistance GeneMicrobiology spectrum · 2023Article
- Linezolid-Resistant Enterococcus faecalis of Chicken Origin Harbored Chromosome-BorneMicrobiology spectrum · 2023Article
- Prevalence and Genetic Analysis of Resistance Mechanisms of Linezolid-Nonsusceptible Enterococci in a Tertiary Care Hospital Examined via Whole-Genome Sequencing.Antibiotics (Basel, Switzerland) · 2022Article
- Emergence and Genomic Characterization of the First ReportedFoods (Basel, Switzerland) · 2022Article
- Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics.Nature communications · 2022Article
- Characterization of a Novel Linezolid Resistance GeneMicrobiology spectrum · 2022Article
- Emergence ofInfection and drug resistance · 2022Article
- Molecular characterization of florfenicol and oxazolidinone resistance inFrontiers in microbiology · 2022Article
- Antimicrobial resistance among canine enterococci in the northeastern United States, 2007-2020.Frontiers in microbiology · 2022Article
- Genetic Context ofAntimicrobial agents and chemotherapy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.